Metabolic syndrome in general practitioner’s surgery
Authors:
K. Kučera 1; J. Malinovská 2; M. Jenšovský 2; M. Lustigová 3,4; J. Brož 2
Authors place of work:
Klinikum Darmstadt GmbH, Darmstadt, Německo
1; Interní klinika 2. LF UK a FN Motol, Praha, Přednosta: prof. MUDr. Milan Kvapil CSc., MBA
2; Přírodovědecká fakulta UK, Praha, Děkan: prof. RNDr. Jiří Zima, CSc.
3; Státní zdravotní ústav, Praha, Ředitel: MUDr. Pavel Březovský, MBA
4
Published in the journal:
Prakt. Lék. 2020; 100(4): 182-185
Category:
Of different specialties
Summary
The metabolic syndrome refers to a group of diseases and risk factors whose co-occurrence increases the risk of specific health complications. According to current recommendations, the so-called harmonized definition of metabolic syndrome is used in the Czech Republic. Its parts include abdominal obesity, hyperglycaemia, hypertension and dyslipidaemia. Patients with metabolic syndrome have up to three times higher risk of cardiovascular diseases, up to two times higher risk of stroke and up to five times higher risk of type 2 diabetes. The prevalence of metabolic syndrome is increasing, the latest survey from 2006–2009 reported 37,5% of men and 25,9% of women in the Czech Republic with metabolic syndrome. Its screening in general practitioner offices is important and should be done regularly. Patients with fully or partially expressed metabolic syndrome should be encouraged to change their lifestyle.
Keywords:
obesity – prevention – screening – metabolic syndrome
Zdroje
1. Alberti G, Zimmet P, Shaw J, Grundy SM. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: International Diabetes Federation 2006.
2. Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med 2011; 9: 48.
3. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010; 56: 1113–1132.
4. Alberti G, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23(5): 469–480.
5. Kasper DL, Fauci AS, Hauser SL, et al. Harrisons Innere Medizin. Stuttgart: Thieme 2017.
6. Mayer O, Bruthans J, Seidlerova J, et al. Prospective study of metabolic syndrome as a mortality marker in chronic coronary heart disease patients. Eur J Intern Med 2018; 47: 55–61.
7. Al-Hamad D, Raman V. Metabolic syndrome in children and adolescents. Transl Pediatr 2017; 6(4): 397–407.
8. Parikh RM, Mohan V. Changing definitions of metabolic syndrome. Indian J Endocrinol Metab 2012; 16(1): 7–12.
9. Reaven GM. Role of insulin resistance in human disease. Banting Lecture 1988. Diabetes 1988; 37: 1595–1607.
10. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120(16): 1640–1645.
11. Karen I, Souček M, Rosolová H, a kol. Doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře. Metabolický syndrom. Praha: Společnost všeobecného lékařství 2014.
12. Hlúbik P, Svačina Š, Sucharda P, a kol. Doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře. Obezita. Praha: Společnost všeobecného lékařství 2014.
13. Šrámková P. Novinky ve farmakoterapii obezity. Gastroent Hepatol 2018; 72(6): 495–500.
14. Kunešová M. Obezita – etiopatogeneze, diagnostika a léčba. Interní Med 2004; 6(9): 435–440.
15. Hoyas I, Leon-Sanz M. Nutritional challenges in metabolic syndrome. J Clin Med 2019; 8(9): 1301.
16. Suliga E, Koziel D, Gluszek S. Prevalence of metabolic syndrome in normal weight individuals. Ann Agric Environ Med 2016; 23(4): 631–635.
17. Perušičová J, Pelikánová T, Škrha J, a kol. Doporučený postup péče o nemocné s prediabetem. Praha: Společné doporučení České diabetologické společnosti ČLS JEP a České internistické společnosti ČLS JEP 2012.
18. Cífková R. Epidemiologie metabolického syndromu ve světě a v České republice. Ústní sdělení na Symposiu o syndromu inzulinové rezistence, Praha 26.–27. února 2003.
19. Cífková R, Škodová Z, Bruthans J. Longitudinal trends in the prevalence of the metabolic syndrome in the Czech population from 1997–8 to 2006–9. The Czech post-MONICA Study. Abstract for the Conference of ECRP, Praha 2010.
20. Kučerová, K, Brabec M, Janíčková Žďárská D, a kol. Student-organized street screening for diabetes mellitus syndrome: Mere celebration of World Diabetes Day or actual preventive and diagnostic Step? Diabetes Res Clin Pract 2016; 118: 67–68.
21. Li R, Li W, Lun Z, et al. Prevalence of metabolic syndrome in mainland China: a meta-analysis of published studies. BMC Public Health 2016; 16: 296.
22. Scuteri A, Laurent S, Cucca F, et al. Metabolic syndrome across Europe: different clusters of risk factors. Eur J Prev Cardiol 2015; 22(4): 486–491.
23. Fernández-Ruiz VE, Paniagua-Urbano JA, Solé-Agustí M, et al. Prevalence of metabolic syndrome and cardiovascular risk in an urban area of Murcia. Nutr Hosp 2014; 30(5): 1077–1083.
24. Janszky I, Vatten L, Romundstad P, et al. Metabolic syndrome in Poland – the PONS Study. Ann Agric Environ Med 2011; 18(2): 270–272.
25. Balhara YPS. Tobacco and metabolic syndrome. Indian J Endocrinol Metab 2012; 16(1): 81–87.
26. Nakanishi N, Takatorige T, Suzuki K. Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. Ind Health 2005; 43(2): 295–301.
27. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2003; 163: 427–436.
28. Kim SK, Hong S-H, Chung J-H, Cho KB. Association between alcohol consumption and metabolic syndrome in a community-based cohort of Korean adults. Med Sci Monit 2017; 23: 2104–2110.
29. Vieira BA, Luft VC, Schmidt MI, et al. Timing and type of alcohol consumption and the metabolic syndrome – ELSA-Brasil. PLoS One 2016; 11(9): e0163044.
30. Dunkley AJ, Stone AM, Patel N, et al. Waist circumference measurement: knowledge, attitudes and barriers in patients and practitioners in a multi-ethnic population. Family Practice 2009; 26(5): 365–371.
31. Bak-Sosnowska M, Skrzypulec-Plinta V. Health behaviors, health definitions, sense of coherence, and general practitioners’ attitudes towards obesity and diagnosing obesity in patients. Arch Med Sci 2017; 13: 433–440.
32. Aguilar M, Bhuket T, Torres S, et al. Prevalence of the metabolic syndrome in the United States 2003–2012. JAMA 2015; 313(19): 1973–1974.
Štítky
General practitioner for children and adolescents General practitioner for adultsČlánok vyšiel v časopise
General Practitioner
2020 Číslo 4
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Memantine Eases Daily Life for Patients and Caregivers
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
Najčítanejšie v tomto čísle
- Manifestations of infectious diseases in the oral cavity
- ERAS concept and its contribution to intensive care
- Laryngocele – current view of the issue
- Two current pandemics: obesity and COVID-19